DD vs XTNT · P/E 127, rev $12.39B vs rev $133.9M
Dupont De Nemours Inc (DD) versus Xtant Medical Holdings Inc (XTNT) — a side-by-side from cached financials, not a winner call.
Dupont De Nemours Inc (DD) is a specialty chemicals company listed on US.
Xtant Medical Holdings Inc (XTNT) is a medical devices company listed on US.
Latest reported DD revenue for 2024-12-31 was $12.39B. Net income was $738.0M. Revenue was up 2.6% from 2023-12-31 to 2024-12-31. DD currently screens at market cap $19.61B and trailing P/E 127.4.
Latest reported XTNT revenue for 2025-12-31 was $133.9M. Net income was $5.0M. Revenue was up 14.2% from 2024-12-31 to 2025-12-31. XTNT currently screens at market cap $91.0M.
DD currently screens at market cap $19.61B and trailing P/E 127.4. XTNT currently screens at market cap $91.0M.
Not investment advice. Open the DD and XTNT stock pages for the full models.
Not investment advice.